3-FLUORO-4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME
Star0
Identification
- Generic Name
- 3-FLUORO-4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME
- DrugBank Accession Number
- DB08334
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 265.2801
Monoisotopic: 265.111421588 - Chemical Formula
- C14H16FNO3
- Synonyms
- Not Available
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Avoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events & improve clinical decision support.
- Pharmacodynamics
Not Available
- Mechanism of action
Target Actions Organism UMacrophage migration inhibitory factor Not Available Humans - Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as o-fluorophenols. These are fluorophenols carrying a iodine at the C2 position of the benzene ring.
- Kingdom
- Organic compounds
- Super Class
- Benzenoids
- Class
- Phenols
- Sub Class
- Halophenols
- Direct Parent
- O-fluorophenols
- Alternative Parents
- Fluorobenzenes / 1-hydroxy-2-unsubstituted benzenoids / Aryl fluorides / Oxime esters / Carboxylic acid salts / Monocarboxylic acids and derivatives / Organopnictogen compounds / Organofluorides / Organic salts / Organic oxides show 2 more
- Substituents
- 1-hydroxy-2-unsubstituted benzenoid / 2-fluorophenol / Aromatic homomonocyclic compound / Aryl fluoride / Aryl halide / Carbonyl group / Carboxylic acid derivative / Carboxylic acid salt / Fluorobenzene / Halobenzene show 13 more
- Molecular Framework
- Aromatic homomonocyclic compounds
- External Descriptors
- Not Available
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- Not Available
- CAS number
- Not Available
- InChI Key
- NPVNUGQNVVMJJP-CXUHLZMHSA-N
- InChI
- InChI=1S/C14H16FNO3/c15-12-8-10(6-7-13(12)17)9-16-19-14(18)11-4-2-1-3-5-11/h6-9,11,17H,1-5H2/b16-9+
- IUPAC Name
- (E)-[(3-fluoro-4-hydroxyphenyl)methylidene]amino cyclohexanecarboxylate
- SMILES
- OC1=CC=C(\C=N\OC(=O)C2CCCCC2)C=C1F
References
- General References
- Not Available
- External Links
- PubChem Compound
- 23655000
- PubChem Substance
- 99444805
- ChemSpider
- 22377908
- ZINC
- ZINC000016052313
- PDBe Ligand
- OX4
- PDB Entries
- 2oow
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.0476 mg/mL ALOGPS logP 3.75 ALOGPS logP 3.79 Chemaxon logS -3.8 ALOGPS pKa (Strongest Acidic) 7.97 Chemaxon pKa (Strongest Basic) 1.57 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 3 Chemaxon Hydrogen Donor Count 1 Chemaxon Polar Surface Area 58.89 Å2 Chemaxon Rotatable Bond Count 4 Chemaxon Refractivity 69.01 m3·mol-1 Chemaxon Polarizability 26.83 Å3 Chemaxon Number of Rings 2 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption + 0.9956 Blood Brain Barrier + 0.9168 Caco-2 permeable + 0.562 P-glycoprotein substrate Non-substrate 0.6658 P-glycoprotein inhibitor I Non-inhibitor 0.6324 P-glycoprotein inhibitor II Non-inhibitor 0.8383 Renal organic cation transporter Non-inhibitor 0.7493 CYP450 2C9 substrate Non-substrate 0.7801 CYP450 2D6 substrate Non-substrate 0.8276 CYP450 3A4 substrate Non-substrate 0.5753 CYP450 1A2 substrate Inhibitor 0.5368 CYP450 2C9 inhibitor Non-inhibitor 0.6432 CYP450 2D6 inhibitor Non-inhibitor 0.9087 CYP450 2C19 inhibitor Inhibitor 0.5292 CYP450 3A4 inhibitor Non-inhibitor 0.8995 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.7379 Ames test Non AMES toxic 0.6379 Carcinogenicity Non-carcinogens 0.778 Biodegradation Not ready biodegradable 0.9703 Rat acute toxicity 2.7448 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.8315 hERG inhibition (predictor II) Non-inhibitor 0.7666
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS Not Available Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available
Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock newinsights and accelerate drug research.
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
1. DetailsMacrophage migration inhibitory factor
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- General Function
- Receptor binding
- Specific Function
- Pro-inflammatory cytokine. Involved in the innate immune response to bacterial pathogens. The expression of MIF at sites of inflammation suggests a role as mediator in regulating the function of ma...
- Gene Name
- MIF
- Uniprot ID
- P14174
- Uniprot Name
- Macrophage migration inhibitory factor
- Molecular Weight
- 12476.19 Da
References
- Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]
Drug created at September 15, 2010 21:30 / Updated at June 12, 2020 16:52